| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.08 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.1 | 0.09 |